ArticleBMJ open2024

Predicting response to iron supplementation in patients with active inflammatory bowel disease (PRIme): a randomised trial protocol.

Roberta Loveikyte et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.